PROCOS — a wholly owned subsidiary of the Japanese CBC Co., Ltd. — is a CDMO that specializes in the development, scale-up, and production of APIs, advanced intermediates, and related products for the pharmaceutical industry. Based in Cameri, Italy, the company's core services are custom synthesis and API manufacturing under GMP conditions. In addition to robust generics manufacturing, they also provide R&D and small-scale HPAPI manufacturing. As of October, 2025, the company was out of business.